Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Palmar-plantar Erythrodysesthesia”

55 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 55 results

Large-scale testing (Phase 3)Study completedNCT00296036
What this trial is testing

Pyridoxine and Topical Urea/Lactic Acid-Based Cream in Preventing Hand-Foot Syndrome in Patients Receiving Capecitabine for Breast Cancer or Other Cancer

Who this might be right for
Breast CancerDrug/Agent Toxicity by Tissue/OrganUnspecified Adult Solid Tumor, Protocol Specific
Alliance for Clinical Trials in Oncology 137
Testing effectiveness (Phase 2)WithdrawnNCT01097850
What this trial is testing

Topical Henna Preparation for the Treatment of Hand Foot Skin Syndrome

Who this might be right for
Hand Foot Skin Syndrome
Northwestern University
Not applicableStudy completedNCT02625415
What this trial is testing

The Topical Application of Vitamin B6 in Palmar-Plantar Erythrodysesthesia

Who this might be right for
Palmar-Plantar Erythrodysesthesia
Cyprus University of Technology 54
Testing effectiveness (Phase 2)UnknownNCT04833998
What this trial is testing

Hydration Based on Thoitaine, Aloe Vera and Calendula, in the Prevention of Hand-Foot Syndrome in Patients Using Capecitabine

Who this might be right for
Hand-foot Syndrome
Instituto Brasileiro de Controle do Cancer 54
Not applicableStudy completedNCT00743431
What this trial is testing

Caelyx in Ovarian Cancer: Prevention and Treatment of Infusion Reactions and Palmar-plantar Erythrodysesthesia (Study P04085)(COMPLETED)

Who this might be right for
Ovarian Neoplasms
Merck Sharp & Dohme LLC 224
Not applicableUnknownNCT06441513
What this trial is testing

The Preventive Effect of Chemotherapy-induced Hand-foot Syndrome

Who this might be right for
Cancer
Peking University Third Hospital 130
Testing effectiveness (Phase 2)Ended earlyNCT00751101
What this trial is testing

Nicotine Patches in Reducing Hand-Foot Syndrome in Patients Who Are Receiving Capecitabine For Metastatic Breast Cancer

Who this might be right for
Breast CancerChemotherapeutic Agent ToxicityPalmar-plantar Erythrodysesthesia
University of California, San Francisco 24
Large-scale testing (Phase 3)Active Not RecruitingNCT05165069
What this trial is testing

The Efficacy and Safety of Mecobalamin in the Prevention of Capecitabine Induced Hand Foot Syndrome

Who this might be right for
Hand-foot Syndrome
Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University 234
Testing effectiveness (Phase 2)Study completedNCT00248248
What this trial is testing

DOXIL for Consolidation Therapy in Ovarian Cancer.

Who this might be right for
Ovarian Neoplasm
Southeastern Gynecologic Oncology 45
Large-scale testing (Phase 3)UnknownNCT05348278
What this trial is testing

Urea Cream Prevention for Capecitabine Associated Hand Foot Syndrome

Who this might be right for
Hand-Foot Syndrome
Mahidol University 214
Large-scale testing (Phase 3)Study completedNCT00661102
What this trial is testing

Prophylactic Treatment for Hand-Foot Syndrome in Patients Treated With Oral Xeloda (Capecitabine).

Who this might be right for
Breast Cancer
Hoffmann-La Roche 598
Testing effectiveness (Phase 2)Study completedNCT05641246
What this trial is testing

Effect of Topical Diclofenac on Clinical Outcome in Breast Cancer Patients Treated With Capecitabine

Who this might be right for
Hand and Foot Syndrome
German University in Cairo 86
Large-scale testing (Phase 3)Ended earlyNCT00305643
What this trial is testing

Celecoxib in Preventing Hand/Foot Syndrome Caused By Capecitabine With Metastatic Breast or Colorectal Cancer

Who this might be right for
Breast CancerColorectal CancerPain
M.D. Anderson Cancer Center 11
Not applicableStudy completedNCT07177560
What this trial is testing

Topical Diclofenac for Hand-Foot Syndrome Prevention in Colorectal and Gastric Cancer on Capecitabine (DICLO-HFS)

Who this might be right for
Colorectal CancerGastric Cancer (GC)Capecitabine+1 more
Gazi University 151
Early research (Phase 1)Ended earlyNCT00827580
What this trial is testing

Eniluracil Hand Foot Syndrome

Who this might be right for
Breast CancerColon Cancer
West Virginia University 3
Not applicableStudy completedNCT04592731
What this trial is testing

Acetylated Natural Nucleotides in Treating Hand-foot Syndrome

Who this might be right for
Hand-foot Syndrome
Nan xu 21
Not applicableUnknownNCT05949307
What this trial is testing

The Efficacy of Acupuncture and Laser Acupuncture in Treating Chemotherapy or Target Therapy-induced Hand-foot Syndrome

Who this might be right for
Hand-Foot Syndrome
China Medical University Hospital 60
Not applicableUnknownNCT06188000
What this trial is testing

Efficacy of Extra Virgin Olive Oil (EVOO) Supplementation on Hand-Foot Syndrome Incidence in Patients With Capecitabine

Who this might be right for
Hand and Foot Skin ReactionHand and Foot SyndromeCapecitabine
Universitas Sriwijaya 60
Early research (Phase 1)Study completedNCT01219023
What this trial is testing

Treatment of Palmar Plantar Erythrodysesthesia (PPE) With Topical Sildenafil

Who this might be right for
Hand Foot SyndromePalmar Plantar Erythrodysesthesia
Duke University 10
Large-scale testing (Phase 3)Study completedNCT01918852
What this trial is testing

S-1 Versus Capecitabine in the First Line Treatment of MCC Patients.

Who this might be right for
Colorectal CancerMetastases
Dutch Colorectal Cancer Group 161
Load More Results